Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Cisplatin × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 114 Squamous Cell Carcinoma of Head and Neck 67 Lung Neoplasms 44 Head and Neck Neoplasms 37 Urinary Bladder Neoplasms 36 Parkinson Disease 4, Autosomal Dominant Lewy Body 28 Biliary Tract Neoplasms 28 Uterine Cervical Neoplasms 27 Nasopharyngeal Carcinoma 27 Cholangiocarcinoma 25 Oropharyngeal Neoplasms 22 Esophageal Squamous Cell Carcinoma 22 Carcinoma 21 Ovarian Neoplasms 18 Neoplasm Metastasis 18 Esophageal Neoplasms 18 Colorectal Neoplasms 18 Carcinoma, Squamous Cell 18 Neoplasms 17 Mesothelioma, Malignant 15 Gallbladder Neoplasms 15 Carcinoma, Transitional Cell 15 Stomach Neoplasms 14 Small Cell Lung Carcinoma 12 Laryngeal Neoplasms 11 Pancreatic Neoplasms 10 Mouth Neoplasms 10 Breast Neoplasms 10 Hypopharyngeal Neoplasms 9 Triple Negative Breast Neoplasms 8

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡